Ukrainian Scientists Feel Helpless at Antarctic Base as War Rages

Ukranian scientists at the Vernadsky Antarctic base hold a national flag Oksana SAVENKO Ukrainian Antarctic Akademik Vernadsky Station/AFP
Ukranian scientists at the Vernadsky Antarctic base hold a national flag Oksana SAVENKO Ukrainian Antarctic Akademik Vernadsky Station/AFP
TT

Ukrainian Scientists Feel Helpless at Antarctic Base as War Rages

Ukranian scientists at the Vernadsky Antarctic base hold a national flag Oksana SAVENKO Ukrainian Antarctic Akademik Vernadsky Station/AFP
Ukranian scientists at the Vernadsky Antarctic base hold a national flag Oksana SAVENKO Ukrainian Antarctic Akademik Vernadsky Station/AFP

For a dozen Ukrainian scientists thousands of kilometers from home at the Vernadsky Antarctic base, the biting cold hurts less than the feeling of helplessness over the war in their homeland.

They spend their days measuring, observing, analyzing and doing their jobs as best they can as a way of coping with the situation, AFP said.

"At the beginning, we didn't sleep for a few days. The whole time we were following news about our home cities," meteorologist Anastasiia Chyhareva, 26, told AFP in messages sent from the base.

Once the invasion was in full swing, the scientists started waking at 2:00 am -- 7:00 am in Ukraine -- to check in on family and see how their night went.

"Now, we're used to it... used to checking news in the morning and before going to bed, in every free minute."

The Ukrainian base is situated on Galindez island, some 1,200 kilometers (745 miles) from Tierra del Fuego in the far south of Argentina.

It is occupied all year round by a dozen people who have to endure temperatures that drop to -20 degrees Celsius (-4 degrees Fahrenheit) in winter.

The scientists' duties include observing meteorological, geophysical, geological and biological conditions, unless the weather forces them to shelter at the base.

"My first impression was like all these things happened in another universe, not our world," said geophysicist Oleksandr Koslokov, whose family lived in war-torn Kharkiv, a heavily targeted city just 40 kilometers from the Russian border.

"I started advising my family on what to do. I had no time to reflect. I had to help my family to survive and to escape from my city... before it became a burning and unpredictable hell.

"My wife heard and felt the explosions of cruise missiles 10 minutes after (Russian President Vladimir) Putin started this stupid and criminal war."

Since then, his family has fled to Germany.

- 'Our part of the war' -
At the base, which is named after a Soviet mineralogist and geochemist with Russian and Ukrainian roots, the scientists try to live as normal a life as possible. Sunday is a day off and Saturday night everyone has dinner together before playing board games and musical instruments.

"It is hard to be so far away from my family and have no possibility to support them," said biologist Artem Dzhulai, 34.

"At the station now, there is a wide range of feelings -- from sadness due to anxiety for relatives and friends, to high spirits, due to pride in our army and the people who are bravely fighting for the right to live in a free country," said marine biologist Oksana Savenko, who is studying humpback whales.

Giving practical advice, moral support, donating to the Ukrainian army, signing a petition, creating online lectures to divert Ukrainian children's attention from the war: the scientists are trying every means available to help in some way.

"It is our part of the war" effort, said Chyhareva.

Ukrainians "try to help each other, they try to help our compatriots, they try to help our army," said another scientist who requested to remain anonymous.

- 'Don't forget us' -
Dzhulai still remains bitter over the West's response the last time Russia invaded Ukraine, annexing Crimea in 2014.

"All democratic countries were indifferent to that act of violence," he said.

"Probably, they hoped that they will not be affected by someone else's grief... but everything can change if evil is not stopped and punished.

"A lot of children in Ukraine died because of the indifference of Europe and the US."

There is fear that the same could happen again.

"Please, don't forget about us after one month, don't be tired of Ukraine and our problems," said Chyhareva.

This team will be replaced later this month, and with their homeland in flames, the departing scientists face an uncertain future.

"I don't have any real plans," said Chychareva, who just hopes to go "back to Ukraine as soon as it will be possible."

"My university in Kharkiv where I studied was destroyed ... my research institute and scientific equipment in Ukraine are destroyed," said Koslokov.

He said he would likely try to continue doing science in Europe or America, adding "time will tell."



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”